K2 Principal Fund, L.P. Lumos Pharma, Inc. Transaction History

K2 Principal Fund, L.P.

  • $210 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 10, 2023
SELL
$3.05 - $9.52 $122,091 - $381,085
-40,030 Reduced 71.65%
15,836 $57,000
Q3 2022

Nov 14, 2022
BUY
$7.35 - $9.05 $318,776 - $392,507
43,371 Added 347.11%
55,866 $494,000
Q2 2022

Aug 12, 2022
BUY
$6.68 - $9.39 $83,466 - $117,328
12,495 New
12,495 $96,000

Others Institutions Holding LUMO

# of Institutions
33
Shares Held
2.2M
Call Options Held
0
Put Options Held
0
View Full List

About LUMOS PHARMA, INC.

LUMO Quotes by TradingView
  • Ticker LUMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 8,396,070
  • Market Cap $36.4M
  • Description
  • Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...
More about LUMO
Track This Portfolio

Track K2 Principal Fund, L.P. Portfolio

Follow K2 Principal Fund, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

News

Stay updated on K2 Principal Fund, L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email